Osteoporosis Treatment Now Approved In Europe And US For Men
Tue, 22 Aug 2006 04:00 AM EST
... The US Food and Drug Administration (FDA) this week approved Actonel® 35mg (risedronate sodium tablets) for 'treatment to increase bone mass in men with osteoporosis'. This follows the positive outcome in July 2006 of the European application for the additional indication of 'treatment of osteoporosis in men at high risk of fracture'. [click link for full article] ...
Related Topics
- Osteoporosis
- Men's Health
- Multiple endocrine neoplasia type 2
- Multiple Endocrine Neoplasia Type 1
- Europe, Western
- Eastern Europe and Northern Asia
- Incontinence in Men
- Treatment
- Treatments
- Hyperthyroidism
- Periodontal Disease
- Exelon
- Travel
- Pamidronate Injection
- Teriparatide Injection
- Vitamin D
- Sodium Flouride
- Zoledronic Acid for Injection
- ALP
- Raloxifene

Not Signed In -


